New Drug may Offer Relief for Patients With Rheumatoid Arthritis

by Karthika on  June 16, 2008 at 6:02 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

New Drug may Offer Relief for Patients With Rheumatoid Arthritis
Trials of a new medicine, called Tocilizumab, suggest that it is thrice as effective at halting the progression of rheumatoid arthritis as the standard therapy given to most patients.

The research also shows that the medicine can even benefit patients who are running out of treatment options.

Although Tocilizumab has not been licensed for use in Europe or the UK as yet, it is likely to be launched in Britain within six months.

It is a laboratory-made antibody, which works by targeting a biological signalling pathway linked to inflammation and the disease, reports the Scotsman.

Rheumatoid arthritis, the crippling auto-immune disease which attacks the joints, is the biggest cause of disability in the UK.

Source: ANI
KAR

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Drug Toxicity Rheumatoid Arthritis Clinical Trials - Different Phases of the trial Oligoarthritis Chemotherapy Signature Drug Toxicity Knee Replacement Reiter’s syndrome Arthritis 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive